# SonoVue Guided Prostate Biopsy

> **NCT00911027** · PHASE3 · TERMINATED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 282 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Contrast-enhanced ultrasound guided biopsy
- **PROCEDURE:** ultrasound guided systematic biopsy

## Key facts

- **NCT ID:** NCT00911027
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 282 (ACTUAL)
- **Why stopped:** Failure to meet primary objective
- **Last updated:** 2012-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911027, "SonoVue Guided Prostate Biopsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00911027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*